Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine with Etoposide and Cyclophosphamide in Relapsed/Refractory AML
NCT00939653Phase 2Terminated
- Sponsor
- Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium
- Start
- Jul 2009
- Primary completion
- Jul 2011
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in acute myeloid leukemia (AML), sponsored by Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium. Started Jul 2009; status: terminated.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00939653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00939653.